Global Artificial Vital Organs And Medical Bionics Market Research Report 2021

1 Artificial Vital Organs and Medical Bionics Market Overview
1.1 Product Overview and Scope of Artificial Vital Organs and Medical Bionics
1.2 Artificial Vital Organs and Medical Bionics Segment by Type
1.2.1 Global Artificial Vital Organs and Medical Bionics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Artificial Vital Organs
1.2.3 Bionics
1.3 Artificial Vital Organs and Medical Bionics Segment by Application
1.3.1 Artificial Vital Organs and Medical Bionics Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Artificial Vital Organs and Medical Bionics Market Size Estimates and Forecasts
1.4.1 Global Artificial Vital Organs and Medical Bionics Revenue 2016-2027
1.4.2 Global Artificial Vital Organs and Medical Bionics Sales 2016-2027
1.4.3 Artificial Vital Organs and Medical Bionics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artificial Vital Organs and Medical Bionics Market Competition by Manufacturers
2.1 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artificial Vital Organs and Medical Bionics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artificial Vital Organs and Medical Bionics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artificial Vital Organs and Medical Bionics Manufacturing Sites, Area Served, Product Type
2.5 Artificial Vital Organs and Medical Bionics Market Competitive Situation and Trends
2.5.1 Artificial Vital Organs and Medical Bionics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Vital Organs and Medical Bionics Players Market Share by Revenue
2.5.3 Global Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artificial Vital Organs and Medical Bionics Retrospective Market Scenario by Region
3.1 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
3.3.1 North America Artificial Vital Organs and Medical Bionics Sales by Country
3.3.2 North America Artificial Vital Organs and Medical Bionics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
3.4.1 Europe Artificial Vital Organs and Medical Bionics Sales by Country
3.4.2 Europe Artificial Vital Organs and Medical Bionics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Vital Organs and Medical Bionics Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Vital Organs and Medical Bionics Sales by Region
3.5.2 Asia Pacific Artificial Vital Organs and Medical Bionics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
3.6.1 Latin America Artificial Vital Organs and Medical Bionics Sales by Country
3.6.2 Latin America Artificial Vital Organs and Medical Bionics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Sales by Country
3.7.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Artificial Vital Organs and Medical Bionics Historic Market Analysis by Type
4.1 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Type (2016-2021)
4.2 Global Artificial Vital Organs and Medical Bionics Revenue Market Share by Type (2016-2021)
4.3 Global Artificial Vital Organs and Medical Bionics Price by Type (2016-2021)

5 Global Artificial Vital Organs and Medical Bionics Historic Market Analysis by Application
5.1 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Application (2016-2021)
5.2 Global Artificial Vital Organs and Medical Bionics Revenue Market Share by Application (2016-2021)
5.3 Global Artificial Vital Organs and Medical Bionics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Abiomed, Inc.
6.2.1 Abiomed, Inc. Corporation Information
6.2.2 Abiomed, Inc. Description and Business Overview
6.2.3 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abiomed, Inc. Product Portfolio
6.2.5 Abiomed, Inc. Recent Developments/Updates
6.3 Asahi Kasei Medical Co., Ltd.
6.3.1 Asahi Kasei Medical Co., Ltd. Corporation Information
6.3.2 Asahi Kasei Medical Co., Ltd. Description and Business Overview
6.3.3 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Asahi Kasei Medical Co., Ltd. Product Portfolio
6.3.5 Asahi Kasei Medical Co., Ltd. Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Baxter Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Cyberonics, Inc.
6.5.1 Cyberonics, Inc. Corporation Information
6.5.2 Cyberonics, Inc. Description and Business Overview
6.5.3 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Cyberonics, Inc. Product Portfolio
6.5.5 Cyberonics, Inc. Recent Developments/Updates
6.6 Edwards
6.6.1 Edwards Corporation Information
6.6.2 Edwards Description and Business Overview
6.6.3 Edwards Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Edwards Product Portfolio
6.6.5 Edwards Recent Developments/Updates
6.7 Ekso Bionics
6.6.1 Ekso Bionics Corporation Information
6.6.2 Ekso Bionics Description and Business Overview
6.6.3 Ekso Bionics Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ekso Bionics Product Portfolio
6.7.5 Ekso Bionics Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Roche Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Fresenius
6.9.1 Fresenius Corporation Information
6.9.2 Fresenius Description and Business Overview
6.9.3 Fresenius Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Fresenius Product Portfolio
6.9.5 Fresenius Recent Developments/Updates
6.10 Baxter International
6.10.1 Baxter International Corporation Information
6.10.2 Baxter International Description and Business Overview
6.10.3 Baxter International Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Baxter International Product Portfolio
6.10.5 Baxter International Recent Developments/Updates
6.11 Iwalk
6.11.1 Iwalk Corporation Information
6.11.2 Iwalk Artificial Vital Organs and Medical Bionics Description and Business Overview
6.11.3 Iwalk Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Iwalk Product Portfolio
6.11.5 Iwalk Recent Developments/Updates
6.12 Jarvik Heart
6.12.1 Jarvik Heart Corporation Information
6.12.2 Jarvik Heart Artificial Vital Organs and Medical Bionics Description and Business Overview
6.12.3 Jarvik Heart Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Jarvik Heart Product Portfolio
6.12.5 Jarvik Heart Recent Developments/Updates
6.13 Medtronic
6.13.1 Medtronic Corporation Information
6.13.2 Medtronic Artificial Vital Organs and Medical Bionics Description and Business Overview
6.13.3 Medtronic Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Medtronic Product Portfolio
6.13.5 Medtronic Recent Developments/Updates
6.14 Micromed Cardiovascular
6.14.1 Micromed Cardiovascular Corporation Information
6.14.2 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Description and Business Overview
6.14.3 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Micromed Cardiovascular Product Portfolio
6.14.5 Micromed Cardiovascular Recent Developments/Updates
6.15 Nikkiso
6.15.1 Nikkiso Corporation Information
6.15.2 Nikkiso Artificial Vital Organs and Medical Bionics Description and Business Overview
6.15.3 Nikkiso Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Nikkiso Product Portfolio
6.15.5 Nikkiso Recent Developments/Updates
6.16 Ossur Hf
6.16.1 Ossur Hf Corporation Information
6.16.2 Ossur Hf Artificial Vital Organs and Medical Bionics Description and Business Overview
6.16.3 Ossur Hf Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Ossur Hf Product Portfolio
6.16.5 Ossur Hf Recent Developments/Updates
6.17 Ottobock
6.17.1 Ottobock Corporation Information
6.17.2 Ottobock Artificial Vital Organs and Medical Bionics Description and Business Overview
6.17.3 Ottobock Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Ottobock Product Portfolio
6.17.5 Ottobock Recent Developments/Updates
6.18 Second Sight Medical Products, Inc.
6.18.1 Second Sight Medical Products, Inc. Corporation Information
6.18.2 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Description and Business Overview
6.18.3 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Second Sight Medical Products, Inc. Product Portfolio
6.18.5 Second Sight Medical Products, Inc. Recent Developments/Updates
6.19 Syncardia Systems, Inc.
6.19.1 Syncardia Systems, Inc. Corporation Information
6.19.2 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Description and Business Overview
6.19.3 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Syncardia Systems, Inc. Product Portfolio
6.19.5 Syncardia Systems, Inc. Recent Developments/Updates
6.20 Thoratec Corporation
6.20.1 Thoratec Corporation Corporation Information
6.20.2 Thoratec Corporation Artificial Vital Organs and Medical Bionics Description and Business Overview
6.20.3 Thoratec Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Thoratec Corporation Product Portfolio
6.20.5 Thoratec Corporation Recent Developments/Updates
6.21 Touch Bionics, Inc.
6.21.1 Touch Bionics, Inc. Corporation Information
6.21.2 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Description and Business Overview
6.21.3 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Touch Bionics, Inc. Product Portfolio
6.21.5 Touch Bionics, Inc. Recent Developments/Updates
6.22 Vital Therapies, Inc.
6.22.1 Vital Therapies, Inc. Corporation Information
6.22.2 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Description and Business Overview
6.22.3 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Vital Therapies, Inc. Product Portfolio
6.22.5 Vital Therapies, Inc. Recent Developments/Updates
6.23 WorldHeart Corporation
6.23.1 WorldHeart Corporation Corporation Information
6.23.2 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Description and Business Overview
6.23.3 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
6.23.4 WorldHeart Corporation Product Portfolio
6.23.5 WorldHeart Corporation Recent Developments/Updates

7 Artificial Vital Organs and Medical Bionics Manufacturing Cost Analysis
7.1 Artificial Vital Organs and Medical Bionics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Vital Organs and Medical Bionics
7.4 Artificial Vital Organs and Medical Bionics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Vital Organs and Medical Bionics Distributors List
8.3 Artificial Vital Organs and Medical Bionics Customers

9 Artificial Vital Organs and Medical Bionics Market Dynamics
9.1 Artificial Vital Organs and Medical Bionics Industry Trends
9.2 Artificial Vital Organs and Medical Bionics Growth Drivers
9.3 Artificial Vital Organs and Medical Bionics Market Challenges
9.4 Artificial Vital Organs and Medical Bionics Market Restraints

10 Global Market Forecast
10.1 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Vital Organs and Medical Bionics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Artificial Vital Organs and Medical Bionics by Type (2022-2027)
10.2 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Vital Organs and Medical Bionics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Artificial Vital Organs and Medical Bionics by Application (2022-2027)
10.3 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Vital Organs and Medical Bionics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Artificial Vital Organs and Medical Bionics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Artificial Vital Organs and Medical Bionics Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Artificial Vital Organs and Medical Bionics Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Artificial Vital Organs and Medical Bionics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Artificial Vital Organs and Medical Bionics Covered in This Study
Table 5. Global Artificial Vital Organs and Medical Bionics Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Artificial Vital Organs and Medical Bionics Sales Share by Manufacturers (2016-2021)
Table 7. Global Artificial Vital Organs and Medical Bionics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Artificial Vital Organs and Medical Bionics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Artificial Vital Organs and Medical Bionics Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Artificial Vital Organs and Medical Bionics Manufacturing Sites and Area Served
Table 11. Manufacturers Artificial Vital Organs and Medical Bionics Product Type
Table 12. Global Artificial Vital Organs and Medical Bionics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Artificial Vital Organs and Medical Bionics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Vital Organs and Medical Bionics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Artificial Vital Organs and Medical Bionics Sales by Region (2016-2021) & (K Units)
Table 16. Global Artificial Vital Organs and Medical Bionics Sales Market Share by Region (2016-2021)
Table 17. Global Artificial Vital Organs and Medical Bionics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) & (K Units)
Table 19. North America Artificial Vital Organs and Medical Bionics Sales Market Share by Country (2016-2021)
Table 20. North America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Artificial Vital Organs and Medical Bionics Revenue Market Share by Country (2016-2021)
Table 22. Europe Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) & (K Units)
Table 23. Europe Artificial Vital Organs and Medical Bionics Sales Market Share by Country (2016-2021)
Table 24. Europe Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Artificial Vital Organs and Medical Bionics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Artificial Vital Organs and Medical Bionics Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Artificial Vital Organs and Medical Bionics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Artificial Vital Organs and Medical Bionics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Artificial Vital Organs and Medical Bionics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Artificial Vital Organs and Medical Bionics Sales Market Share by Country (2016-2021)
Table 32. Latin America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Artificial Vital Organs and Medical Bionics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Artificial Vital Organs and Medical Bionics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue Market Share by Country (2016-2021)
Table 38. Global Artificial Vital Organs and Medical Bionics Sales (K Units) by Type (2016-2021)
Table 39. Global Artificial Vital Organs and Medical Bionics Sales Market Share by Type (2016-2021)
Table 40. Global Artificial Vital Organs and Medical Bionics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Artificial Vital Organs and Medical Bionics Revenue Share by Type (2016-2021)
Table 42. Global Artificial Vital Organs and Medical Bionics Price (USD/Unit) by Type (2016-2021)
Table 43. Global Artificial Vital Organs and Medical Bionics Sales (K Units) by Application (2016-2021)
Table 44. Global Artificial Vital Organs and Medical Bionics Sales Market Share by Application (2016-2021)
Table 45. Global Artificial Vital Organs and Medical Bionics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Artificial Vital Organs and Medical Bionics Revenue Share by Application (2016-2021)
Table 47. Global Artificial Vital Organs and Medical Bionics Price (USD/Unit) by Application (2016-2021)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Business Overview
Table 50. Abbott Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Artificial Vital Organs and Medical Bionics Product
Table 52. Abbott Recent Developments/Updates
Table 53. Abiomed, Inc. Corporation Information
Table 54. Abiomed, Inc. Description and Business Overview
Table 55. Abiomed, Inc. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Abiomed, Inc. Artificial Vital Organs and Medical Bionics Product
Table 57. Abiomed, Inc. Recent Developments/Updates
Table 58. Asahi Kasei Medical Co., Ltd. Corporation Information
Table 59. Asahi Kasei Medical Co., Ltd. Description and Business Overview
Table 60. Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Product
Table 62. Asahi Kasei Medical Co., Ltd. Recent Developments/Updates
Table 63. Baxter Corporation Information
Table 64. Baxter Description and Business Overview
Table 65. Baxter Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Baxter Artificial Vital Organs and Medical Bionics Product
Table 67. Baxter Recent Developments/Updates
Table 68. Cyberonics, Inc. Corporation Information
Table 69. Cyberonics, Inc. Description and Business Overview
Table 70. Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Product
Table 72. Cyberonics, Inc. Recent Developments/Updates
Table 73. Edwards Corporation Information
Table 74. Edwards Description and Business Overview
Table 75. Edwards Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Edwards Artificial Vital Organs and Medical Bionics Product
Table 77. Edwards Recent Developments/Updates
Table 78. Ekso Bionics Corporation Information
Table 79. Ekso Bionics Description and Business Overview
Table 80. Ekso Bionics Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Ekso Bionics Artificial Vital Organs and Medical Bionics Product
Table 82. Ekso Bionics Recent Developments/Updates
Table 83. Roche Corporation Information
Table 84. Roche Description and Business Overview
Table 85. Roche Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Roche Artificial Vital Organs and Medical Bionics Product
Table 87. Roche Recent Developments/Updates
Table 88. Fresenius Corporation Information
Table 89. Fresenius Description and Business Overview
Table 90. Fresenius Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Fresenius Artificial Vital Organs and Medical Bionics Product
Table 92. Fresenius Recent Developments/Updates
Table 93. Baxter International Corporation Information
Table 94. Baxter International Description and Business Overview
Table 95. Baxter International Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Baxter International Artificial Vital Organs and Medical Bionics Product
Table 97. Baxter International Recent Developments/Updates
Table 98. Iwalk Corporation Information
Table 99. Iwalk Description and Business Overview
Table 100. Iwalk Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Iwalk Artificial Vital Organs and Medical Bionics Product
Table 102. Iwalk Recent Developments/Updates
Table 103. Jarvik Heart Corporation Information
Table 104. Jarvik Heart Description and Business Overview
Table 105. Jarvik Heart Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Jarvik Heart Artificial Vital Organs and Medical Bionics Product
Table 107. Jarvik Heart Recent Developments/Updates
Table 108. Medtronic Corporation Information
Table 109. Medtronic Description and Business Overview
Table 110. Medtronic Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Medtronic Artificial Vital Organs and Medical Bionics Product
Table 112. Medtronic Recent Developments/Updates
Table 113. Micromed Cardiovascular Corporation Information
Table 114. Micromed Cardiovascular Description and Business Overview
Table 115. Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Product
Table 117. Micromed Cardiovascular Recent Developments/Updates
Table 118. Nikkiso Corporation Information
Table 119. Nikkiso Description and Business Overview
Table 120. Nikkiso Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Nikkiso Artificial Vital Organs and Medical Bionics Product
Table 122. Nikkiso Recent Developments/Updates
Table 123. Ossur Hf Corporation Information
Table 124. Ossur Hf Description and Business Overview
Table 125. Ossur Hf Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Ossur Hf Artificial Vital Organs and Medical Bionics Product
Table 127. Ossur Hf Recent Developments/Updates
Table 128. Ottobock Corporation Information
Table 129. Ottobock Description and Business Overview
Table 130. Ottobock Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Ottobock Artificial Vital Organs and Medical Bionics Product
Table 132. Ottobock Recent Developments/Updates
Table 133. Second Sight Medical Products, Inc. Corporation Information
Table 134. Second Sight Medical Products, Inc. Description and Business Overview
Table 135. Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Product
Table 137. Second Sight Medical Products, Inc. Recent Developments/Updates
Table 138. Syncardia Systems, Inc. Corporation Information
Table 139. Syncardia Systems, Inc. Description and Business Overview
Table 140. Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Product
Table 142. Syncardia Systems, Inc. Recent Developments/Updates
Table 143. Thoratec Corporation Corporation Information
Table 144. Thoratec Corporation Description and Business Overview
Table 145. Thoratec Corporation Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Thoratec Corporation Artificial Vital Organs and Medical Bionics Product
Table 147. Thoratec Corporation Recent Developments/Updates
Table 148. Touch Bionics, Inc. Corporation Information
Table 149. Touch Bionics, Inc. Description and Business Overview
Table 150. Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Product
Table 152. Touch Bionics, Inc. Recent Developments/Updates
Table 153. Vital Therapies, Inc. Corporation Information
Table 154. Vital Therapies, Inc. Description and Business Overview
Table 155. Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Product
Table 157. Vital Therapies, Inc. Recent Developments/Updates
Table 158. WorldHeart Corporation Corporation Information
Table 159. WorldHeart Corporation Description and Business Overview
Table 160. WorldHeart Corporation Artificial Vital Organs and Medical Bionics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. WorldHeart Corporation Artificial Vital Organs and Medical Bionics Product
Table 162. WorldHeart Corporation Recent Developments/Updates
Table 163. Production Base and Market Concentration Rate of Raw Material
Table 164. Key Suppliers of Raw Materials
Table 165. Artificial Vital Organs and Medical Bionics Distributors List
Table 166. Artificial Vital Organs and Medical Bionics Customers List
Table 167. Artificial Vital Organs and Medical Bionics Market Trends
Table 168. Artificial Vital Organs and Medical Bionics Growth Drivers
Table 169. Artificial Vital Organs and Medical Bionics Market Restraints
Table 170. Global Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027) & (K Units)
Table 171. Global Artificial Vital Organs and Medical Bionics Sales Market Share Forecast by Type (2022-2027)
Table 172. Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 173. Global Artificial Vital Organs and Medical Bionics Revenue Market Share Forecast by Type (2022-2027)
Table 174. Global Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027) & (K Units)
Table 175. Global Artificial Vital Organs and Medical Bionics Sales Market Share Forecast by Application (2022-2027)
Table 176. Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 177. Global Artificial Vital Organs and Medical Bionics Revenue Market Share Forecast by Application (2022-2027)
Table 178. Global Artificial Vital Organs and Medical Bionics Sales Forecast by Region (2022-2027) & (K Units)
Table 179. Global Artificial Vital Organs and Medical Bionics Sales Market Share Forecast by Region (2022-2027)
Table 180. Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 181. Global Artificial Vital Organs and Medical Bionics Revenue Market Share Forecast by Region (2022-2027)
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artificial Vital Organs and Medical Bionics
Figure 2. Global Artificial Vital Organs and Medical Bionics Market Share by Type in 2020 & 2027
Figure 3. Artificial Vital Organs Product Picture
Figure 4. Bionics Product Picture
Figure 5. Global Artificial Vital Organs and Medical Bionics Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Artificial Vital Organs and Medical Bionics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Artificial Vital Organs and Medical Bionics Market Size 2016-2027 (US$ Million)
Figure 11. Global Artificial Vital Organs and Medical Bionics Sales 2016-2027 (K Units)
Figure 12. Global Artificial Vital Organs and Medical Bionics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Artificial Vital Organs and Medical Bionics Sales Share by Manufacturers in 2020
Figure 14. Global Artificial Vital Organs and Medical Bionics Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Artificial Vital Organs and Medical Bionics Players: Market Share by Revenue in 2020
Figure 16. Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Artificial Vital Organs and Medical Bionics Sales Market Share by Region (2016-2021)
Figure 18. Global Artificial Vital Organs and Medical Bionics Sales Market Share by Region in 2020
Figure 19. Global Artificial Vital Organs and Medical Bionics Revenue Market Share by Region (2016-2021)
Figure 20. Global Artificial Vital Organs and Medical Bionics Revenue Market Share by Region in 2020
Figure 21. U.S. Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Artificial Vital Organs and Medical Bionics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Artificial Vital Organs and Medical Bionics by Type (2016-2021)
Figure 46. Sales Market Share of Artificial Vital Organs and Medical Bionics by Application (2016-2021)
Figure 47. Sales Market Share of Artificial Vital Organs and Medical Bionics by Application in 2020
Figure 48. Revenue Share of Artificial Vital Organs and Medical Bionics by Application (2016-2021)
Figure 49. Revenue Share of Artificial Vital Organs and Medical Bionics by Application in 2020
Figure 50. Manufacturing Cost Structure of Artificial Vital Organs and Medical Bionics
Figure 51. Manufacturing Process Analysis of Artificial Vital Organs and Medical Bionics
Figure 52. Artificial Vital Organs and Medical Bionics Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.